Loading Complete
Stuart Grossman

Stuart Grossman, MD

Medical Oncology

Accepting New Patients

Highlights

Languages

  • English

Gender

Male

Johns Hopkins Affiliations:

  • Johns Hopkins School of Medicine Faculty

About Stuart Grossman

Professional Titles

  • Co-Director, Brain Cancer Research Program, Sidney Kimmel Cancer Center

Primary Academic Title

Professor of Oncology

Background

Stuart Grossman, M.D., professor of oncology at the Johns Hopkins Kimmel Cancer Center, is co-Leader of the Brain Cancer Program and has directed the clinical and research neuro-oncology efforts at Johns Hopkins since 1981. He has served as Principal Investigator and Director of the Central Operations office of the National Cancer Institute-funded phase I/II brain tumor consortia (New Approaches to Brain Tumor Therapy CNS Consortium and the Adult Brain Tumor Consortium) for the past 22 years. He has led many phase I, II, and III institutional and cooperative group translational and clinical brain cancer research projects. 

Dr. Grossman's expertise is in brain cancers, translational and clinical research, and directing large, multicenter, multidisciplinary clinical trial groups and training programs.

Dr. Grossman was an intern and resident at Strong Memorial Hospital in Rochester, NY, and a fellow at the Johns Hopkins University School of Medicine. He received his M.D. from the University of Rochester.

Clinical Trial Keywords

cancer pain; brain tumors

Research Interests

brain cancer, cancer pain

Selected Publications

  • Blakeley, J.O.; Grossman, S.A. Management of pineal region tumors. Current Treatment Options in Oncology. 2006 Nov;7(6):505-516.

    Chu, L.C.; Eberhart, C.G.; Grossman, S.A.; Herman, J.G. Epigenetic silencing of multiple genes in primary CNS lymphoma. Int J Cancer. 2006 Nov 15;119(10):2487-2491.

    Gerber, D.E.; Grossman, S.A. Does decompressive surgery improve outcome in patients with metastatic epidural spinal-cord compression? Nature clinical practiceNeurology. 2006 Jan;2(1):10-11.

    Gerber, D.E.; Grossman, S.A.; Streiff, M.B. Management of venous thromboembolism in patients with primary and metastatic brain tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Mar 10;24(8):1310-1318.

    Grossman, S.A.; Carson, K.A.; Batchelor, T.T.; Lesser, G.; Mikkelsen, T.; Alavi, J.B.; Phuphanich, S.; Hammour, T.; Fisher, J.D.; Supko, J.G. The effect of enzyme-inducing antiseizure drugs on the pharmacokinetics and tolerability of procarbazine hydrochloride. Clinical Cancer Res:An Official Journal of the American Association for Cancer Res. 2006 Sep 1;12(17):5174-5181.

    Mathew, B.S.; Carson, K.A.; Grossman, S.A. Initial response to glucocorticoids. Cancer. 2006 Jan 15;106(2):383-387.

    Weaver, K.D.; Grossman, S.A.; Herman, J.G. Methylated tumor-specific DNA as a plasma biomarker in patients with glioma. Cancer investigation. 2006 Feb;24(1):35-40.

    Carson, K.A.; Grossman, S.A.; Fisher, J.D.; Shaw, E.G. Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Jun 20;25(18):2601-2606.

    Gerber, D.E., T. Chan, S. A. Grossman, L. Kleinberg Intracranial Hemorrhage during GliaSite RTS manipulation in an anticoagulated patient. Journal Radiotherapy in Practice. 2007;6 (1):53-57.

    Gerber, D.E.; Grossman, S.A.; Batchelor, T.; Ye, X. Calculated versus measured creatinine clearance for dosing methotrexate in the treatment of primary central nervous system lymphoma. Cancer chemotherapy and pharmacology. 2007 May;59(6):817-823.

    Gerber, D.E.; Grossman, S.A.; Zeltzman, M.; Parisi, M.A.; Kleinberg, L. The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas. Neuro-oncology. 2007 Jan;9(1):47-52.

    Gerber, D.E.; Segal, J.B.; Salhotra, A.; Olivi, A.; Grossman, S.A.; Streiff, M.B. Venous thromboembolism occurs infrequently in meningioma patients receiving combined modality prophylaxis. Cancer. 2007 Jan 15;109(2):300-305.

    Kelloff, G.J.; Sullivan, D.C.; Baker, H.; Clarke, L.P.; Nordstrom, R.; Tatum, J.L.; Dorfman, G.S.; Jacobs, P.; Berg, C.D.; Pomper, M.G.; Birrer, M.J.; Tempero, M.; Higley, H.R.; Petty, B.G.; Sigman, C.C.; Maley, C.; Sharma, P.; Wax, A.; Ginsberg, G.G.; Dannenberg, A.J.; Hawk, E.T.; Messing, E.M.; Grossman, H.B.; Harisinghani, M.; Bigio, I.J.; Griebel, D.; Henson, D.E.; Fabian, C.J.; Ferrara, K.; Fantini, S.; Schnall, M.D.; Zujewski, J.A.; Hayes, W.; Klein, E.A.; DeMarzo, A.; Ocak, I.; Ketterling, J.A.; Tempany, C.; Shtern, F.; Parnes, H.L.; Gomez, J.; Srivastava, S.; Szabo, E.; Lam, S.; Seibel, E.J.; Massion, P.; McLennan, G.; Cleary, K.; Suh, R.; Burt, R.W.; Pfeiffer, R.M.; Hoffman, J.M.; Roy, H.K.; Wang, T.; Limburg, P.J.; El-Deiry, W.S.; Papadimitrakopoulou, V.; Hittelman, W.N.; MacAulay, C.; Veltri, R.W.; Solomon, D.; Jeronimo, J.; Richards-Kortum, R.; Johnson, K.A.; Viner, J.L.; Stratton, S.P.; Rajadhyaksha, M.; Dhawan, A. Workshop on imaging science development for cancer prevention and preemption. Cancer Biomark. 2007;3(1):1-33.

    Mikkelsen, T.; Lush, R.; Grossman, S.A.; Carson, K.A.; Fisher, J.D.; Alavi, J.B.; Rosenfeld, S. Phase II clinical and pharmacologic study of radiation therapy and carboxyamido-triazole (CAI) in adults with newly diagnosed glioblastoma multiforme. Investigational new drugs. 2007 Jun;25(3):259-263.

    Nabors, L.B.; Mikkelsen, T.; Rosenfeld, S.S.; Hochberg, F.; Akella, N.S.; Fisher, J.D.; Cloud, G.A.; Zhang, Y.; Carson, K.; Wittemer, S.M.; Colevas, A.D.; Grossman, S.A. Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 May 1;25(13):1651-1657.

    Peng, T.; Blakeley, J.; Cingolani, E.; Griffiths, E.; Grossman, S.A. Herpes simplex encephalitis in a patient with recurrent pituitary adenoma receiving radiation therapy. American journal of clinical oncology. 2007 Dec;30(6):664-665.

    Weingart, J.; Grossman, S.A.; Carson, K.A.; Fisher, J.D.; Delaney, S.M.; Rosenblum, M.L.; Olivi, A.; Judy, K.; Tatter, S.B.; Dolan, M.E. Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Feb 1;25(4):399-404.

    Blakeley, J.; Grossman, S. Anaplastic oligodendroglioma. Current treatment options in neurology. 2008 Jul;10(4):295-307.

    Brem, S.S.; Bierman, P.J.; Black, P.; Brem, H.; Chamberlain, M.C.; Chiocca, E.A.; DeAngelis, L.M.; Fenstermaker, R.A.; Friedman, A.; Gilbert, M.R.; Glass, J.; Grossman, S.A.; Heimberger, A.B.; Junck, L.; Linette, G.P.; Loeffler, J.J.; Maor, M.H.; Moots, P.; Mrugala, M.; Nabors, L.B.; Newton, H.B.; Olivi, A.; Portnow, J.; Prados, M.; Raizer, J.J.; Shrieve, D.C.; Sills, A.K., Jr. Central nervous system cancers. Journal of the National Comprehensive Cancer Network : JNCCN. 2008 May;6(5):456-504.

    Chen, H.; Shah, A.S.; Girgis, R.E.; Grossman, S.A. Transmission of glioblastoma multiforme after bilateral lung transplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Jul 1;26(19):3284-3285.

    Easter, J.S.; Grossman, S.A.; Woodruff, M.M.; Rosen, C.L. When the rules do not work: head injury without loss of consciousness. The Journal of emergency medicine. 2008 Jul;35(1):77-80.

    Gerstner, E.R.; Carson, K.A.; Grossman, S.A.; Batchelor, T.T. Long-term outcome in PCNSL patients treated with high-dose methotrexate and deferred radiation. Neurology. 2008 Jan 29;70(5):401-402.

    Grossman, S.A.; Carson, K.A.; Phuphanich, S.; Batchelor, T.; Peereboom, D.; Nabors, L.B.; Lesser, G.; Hausheer, F.; Supko, J.G.; New Approaches to Brain Tumor Therapy, C.N.S.C. Phase I and pharmacokinetic study of karenitecin in patients with recurrent malignant gliomas. Neuro-oncology. 2008 Aug;10(4):608-616.

    Grossman, S.A.; Olson, J.; Batchelor, T.; Peereboom, D.; Lesser, G.; Desideri, S.; Ye, X.; Hammour, T.; Supko, J.G.; New Approaches to Brain Tumor Therapy, C.N.S.C. Effect of phenytoin on celecoxib pharmacokinetics in patients with glioblastoma. Neuro-oncology. 2008 Apr;10(2):190-198.

    Blakeley, J.O.; Olson, J.; Grossman, S.A.; He, X.; Weingart, J.; Supko, J.G.; New Approaches to Brain Tumor Therapy, C. Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study. Journal of neuro-oncology. 2009 Jan;91(1):51-58.

    De Jesus, A.; Grossman, S.A.; Paun, O. Cytomegalovirus associated colonic pseudotumor: a consequence of iatrogenic immunosuppression in a patient with primary brain tumor receiving radiation and temozolomide. Journal of neuro-oncology. 2009 Sep;94(3):445-448.

    Grossman, S.A.; Ye, X.; Chamberlain, M.; Mikkelsen, T.; Batchelor, T.; Desideri, S.; Piantadosi, S.; Fisher, J.; Fine, H.A. Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial. J Clin Oncol. 2009 Sep 1;27(25):4155-4161.

    Holdhoff, M.; Supko, J.G.; Gallia, G.L.; Hann, C.L.; Bonekamp, D.; Ye, X.; Cao, B.; Olivi, A.; Grossman, S.A. Intratumoral concentrations of imatinib after oral administration in patients with glioblastoma multiforme. J Neurooncol. 2009 Sep 19;97(2):241-250.

    McGirt, M.J.; Than, K.D.; Weingart, J.D.; Chaichana, K.L.; Attenello, F.J.; Olivi, A.; Laterra, J.; Kleinberg, L.R.; Grossman, S.A.; Brem, H.; Quinones-Hinojosa, A. Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. Journal of neurosurgery. 2009 Mar;110(3):583-588.

    Grossman, R.; Mukherjee, D.; Chang, D.C.; Purtell, M.; Lim, M.; Brem, H.; Quinones-Hinojosa, A. Predictors of Inpatient Death and Complications among Postoperative Elderly Patients with Metastatic Brain Tumors. Annals of surgical oncology. 2010 (Journal Article).

    Grossman, S.A.; Ye, X.; Piantadosi, S.; Desideri, S.; Nabors, L.B.; Rosenfeld, M.; Fisher, J.; Consortium, N.C. Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States. Clinical cancer research : an official journal of the American Association for Cancer Research. 2010;16(8):2443-2449.

    Holdhoff, M.; Supko, J.G.; Gallia, G.L.; Hann, C.L.; Bonekamp, D.; Ye, X.; Cao, B.; Olivi, A.; Grossman, S.A. Intratumoral concentrations of imatinib after oral administration in patients with glioblastoma multiforme. J Neurooncol. 2010 Apr;97(2):241-245.

    Peereboom, D.M.; Supko, J.G.; Carson, K.A.; Batchelor, T.; Phuphanich, S.; Lesser, G.; Mikkelsen, T.; Fisher, J.; Desideri, S.; He, X.; Grossman, S.A.; New Approaches to Brain Tumor Therapy, C. A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas. Journal of neuro-oncology. 2010;100(2):261-268.

    Phuphanich, S.; Supko, J.G.; Carson, K.A.; Grossman, S.A.; Burt Nabors, L.; Mikkelsen, T.; Lesser, G.; Rosenfeld, S.; Desideri, S.; Olson, J.J. Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma. Journal of neuro-oncology. 2010;100(1):95-103.

    Rosenfeld, M.R.; Chamberlain, M.C.; Grossman, S.A.; Peereboom, D.M.; Lesser, G.J.; Batchelor, T.T.; Desideri, S.; Salazar, A.M.; Ye, X. A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma. Neuro-oncology. 2010;12(10):1071-1077.

    Zhou, J.; Tryggestad, E.; Wen, Z.; Lal, B.; Zhou, T.; Grossman, R.; Wang, S.; Yan, K.; Fu, D.X.; Ford, E.; Tyler, B.; Blakeley, J.; Laterra, J.; van Zijl, P.C. Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med. 2011 Jan;17(1):130-134.

Locations

  1. Skip Viragh Outpatient Cancer Center
    • 201 North Broadway Street, Viragh BLDG 5th FL, Baltimore, MD 21287

    Expertise

    Education

    Johns Hopkins University School of Medicine

    Fellowship, Medical Oncology, 1981

    Strong Memorial Hospital

    Residency, Internal Medicine, 1976

    University of Rochester School of Medicine and Dentistry

    Medical Education, MD, 1973

    Board Certifications

    Medical Oncology

    American Board of Internal Medicine, 1983

    Internal Medicine

    American Board of Internal Medicine, 1976

    Insurance

    Johns Hopkins providers accept various commercial health insurance plans. However, they may not be included in all of an insurance company's plans or offerings. This may include Exchange, Medicaid, Medicare, and specific limited benefit plans. Exceptions to participation also exist based on your employer’s benefits package and the provider's location or specialty. Please contact your insurer directly to make sure your doctor is covered by your plan. For more details, please review our Insurance Information.
    Search plans
    • Aetna
    • CareFirst
    • Cigna
    • First Health
    • Geisinger Health Plan
    • HealthSmart/Accel
    • Humana
    • Johns Hopkins Health Plans
    • MultiPlan
    • Pennsylvania's Preferred Health Networks (PPHN)
    • Point Comfort Underwriters
    • Private Healthcare Systems (PHCS)
    • UnitedHealthcare
    • Veteran Affairs Community Care Network (Optum-VACCN)